{"nctId":"NCT00500357","briefTitle":"Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects","startDateStruct":{"date":"2007-11"},"conditions":["Vaccines, Pneumococcal Conjugate Vaccine"],"count":105,"armGroups":[],"interventions":[{"name":"13-valent Pneumococcal Conjugate Vaccine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"* Previous participant of study 6115A1-500 and received 13vPnC +AlPO4 / 23vPS\n* Generally healthy male or female adults 65 years of age or older\n* Available for the duration of the trial - approximately 1 month\n* No history of severe adverse reaction associated with a vaccine\n\n  * MMSE score less than or equal to 21 was an exclusion criteria.","healthyVolunteers":true,"sex":"ALL","minimumAge":"65 Years","stdAges":["OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pneumococcal OPA Geometric Mean Titers (GMTs) for the 13 Serotypes 1 Month After 13vPnC / 23vPS / 13vPnC (Vaccination 3) Versus 1 Month After 13vPnC (Vaccination 1)","description":"Antibody geometric mean titers as measured by opsonophagocytic activity (OPA) assay for 13 pneumococcal serotypes (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Confidence intervals (CI) for the GMTs are back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"198","spread":null},{"groupId":"OG001","value":"78","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"126","spread":null},{"groupId":"OG001","value":"104","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2210","spread":null},{"groupId":"OG001","value":"1254","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"413","spread":null},{"groupId":"OG001","value":"170","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4931","spread":null},{"groupId":"OG001","value":"3158","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3251","spread":null},{"groupId":"OG001","value":"2440","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"869","spread":null},{"groupId":"OG001","value":"353","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"977","spread":null},{"groupId":"OG001","value":"247","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"982","spread":null},{"groupId":"OG001","value":"550","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2860","spread":null},{"groupId":"OG001","value":"1457","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1141","spread":null},{"groupId":"OG001","value":"431","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1014","spread":null},{"groupId":"OG001","value":"494","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"523","spread":null},{"groupId":"OG001","value":"661","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Vaccination 13vPnC / 23vPS / 13vPnC (Vaccination 3)","description":"Local reactions reported using electronic diary. Redness and swelling scaled as Any (redness or swelling present); Mild (2.5 centimeters \\[cm\\] to 5.0 cm); Moderate (5.1 to 10.0 cm); Severe (\\> 10.0 cm). Pain scaled as Any (pain present); Mild (awareness of symptom, easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating, inability to do usual activity). Limitation of arm movement scaled as Any (limitation present); Mild (some limitation); Moderate (unable to move above head, able to move above shoulder); Severe (unable to move shoulder).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Vaccination 13vPnC / 23vPS / 13vPnC (Vaccination 3)","description":"Systemic events reported using electronic diary. Fever scaled as Any (≥38 degrees Celsius \\[C\\]); Mild (≥38 but \\<38.5 degrees C); Moderate (≥38.5 but \\<39 degrees C); Severe (≥39 but ≤40 degrees C); Potentially life-threatening (\\>40 degrees C). Other systemic events include Fatigue, Headache, Chills, Rash, Vomiting, Decreased appetite, New muscle pain, Aggravated muscle pain, New joint pain, and Aggravated joint pain.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Pneumococcal OPA Geometric Mean Titers (GMTs) for the 13 Serotypes 1 Month After 13vPnC / 23vPS / 13vPnC (Vaccination 3) Versus 1 Month After 13vPnC / 23vPS (Vaccination 2)","description":"Antibody geometric mean titers as measured by opsonophagocytic activity (OPA) assay for 13 pneumococcal serotypes (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Confidence intervals (CI) for the GMTs are back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"184","spread":null},{"groupId":"OG001","value":"81","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"131","spread":null},{"groupId":"OG001","value":"104","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1457","spread":null},{"groupId":"OG001","value":"1406","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"326","spread":null},{"groupId":"OG001","value":"219","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1732","spread":null},{"groupId":"OG001","value":"3443","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1862","spread":null},{"groupId":"OG001","value":"2505","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1292","spread":null},{"groupId":"OG001","value":"351","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"624","spread":null},{"groupId":"OG001","value":"267","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"808","spread":null},{"groupId":"OG001","value":"557","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1753","spread":null},{"groupId":"OG001","value":"1452","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"756","spread":null},{"groupId":"OG001","value":"511","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"901","spread":null},{"groupId":"OG001","value":"527","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"484","spread":null},{"groupId":"OG001","value":"731","spread":null}]}]}]},{"type":"SECONDARY","title":"Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentrations (GMCs) for the 13 Serotypes 1 Month After 13vPnC / 23vPS / 13vPnC (Vaccination 3) Versus 1 Month After 13vPnC (Vaccination 1)","description":"Pneumococcal IgG GMCs measured as micrograms per milliliter (mcg/mL) for the 13 pneumococcal serotypes (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Confidence intervals (CI) for the GMCs are back transformations of a CI based on the Student t distribution for the mean logarithm of the concentrations.","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.67","spread":null},{"groupId":"OG001","value":"4.99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.60","spread":null},{"groupId":"OG001","value":"1.35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.68","spread":null},{"groupId":"OG001","value":"2.96","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.51","spread":null},{"groupId":"OG001","value":"6.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.12","spread":null},{"groupId":"OG001","value":"8.22","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.03","spread":null},{"groupId":"OG001","value":"10.32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.93","spread":null},{"groupId":"OG001","value":"5.02","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.56","spread":null},{"groupId":"OG001","value":"5.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.51","spread":null},{"groupId":"OG001","value":"13.34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.59","spread":null},{"groupId":"OG001","value":"7.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.52","spread":null},{"groupId":"OG001","value":"17.80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.39","spread":null},{"groupId":"OG001","value":"8.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.16","spread":null},{"groupId":"OG001","value":"7.73","spread":null}]}]}]},{"type":"SECONDARY","title":"Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentrations (GMCs) for the 13 Serotypes 1 Month After 13vPnC / 23vPS / 13vPnC (Vaccination 3) Versus 1 Month After 13vPnC / 23vPS (Vaccination 2)","description":"Pneumococcal IgG GMCs measured as micrograms per milliliter (mcg/mL) for the 13 pneumococcal serotypes (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Confidence intervals (CI) for the GMCs are back transformations of a CI based on the Student t distribution for the mean logarithm of the concentrations.","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.29","spread":null},{"groupId":"OG001","value":"4.99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.46","spread":null},{"groupId":"OG001","value":"1.36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.93","spread":null},{"groupId":"OG001","value":"2.96","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.29","spread":null},{"groupId":"OG001","value":"6.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.51","spread":null},{"groupId":"OG001","value":"8.22","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.67","spread":null},{"groupId":"OG001","value":"10.32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.41","spread":null},{"groupId":"OG001","value":"5.02","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.60","spread":null},{"groupId":"OG001","value":"5.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.67","spread":null},{"groupId":"OG001","value":"13.34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.66","spread":null},{"groupId":"OG001","value":"7.82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.78","spread":null},{"groupId":"OG001","value":"17.80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.82","spread":null},{"groupId":"OG001","value":"8.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.27","spread":null},{"groupId":"OG001","value":"7.73","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":105},"commonTop":["Fatigue","Headache","Injection site pain","Injection site erythema","Myalgia"]}}}